By Dr Briony Kate Larance

Journal articles

Larance B; Lintzeris N; Bruno R; Peacock A; Cama E; Ali R; Kihas I; Hordern A; White N; Degenhardt L, 2015, 'The characteristics of a cohort who tamper with prescribed and diverted opioid medications', Journal of Substance Abuse Treatment, 58, pp. 51 - 61, http://dx.doi.org/10.1016/j.jsat.2015.06.001

Larance B; Dietze P; Ali R; Lintzeris N; White N; Jenkinson R; Degenhardt L, 2015, 'The introduction of buprenorphine-naloxone film in opioid substitution therapy in Australia: Uptake and issues arising from changing buprenorphine formulations', Drug and Alcohol Review, 34, pp. 603 - 610, http://dx.doi.org/10.1111/dar.12277

Hoban B; Larance B; Gisev N; Nielsen S; Cohen M; Bruno R; Shand F; Lintzeris N; Hall W; Farrell M; Degenhardt L, 2015, 'The use of paracetamol (acetaminophen) among a community sample of people with chronic non-cancer pain prescribed opioids', International Journal of Clinical Practice, 69, pp. 1366 - 1376, http://dx.doi.org/10.1111/ijcp.12716

Degenhardt L; Gisev N; Cama E; Larance B; Bruno R, 2015, 'Estimating the Extent and Predictors of Pharmaceutical Opioid Use in Australia in 2013', PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 24, pp. 25 - 26, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000369980200044&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Campbell G; Nielsen S; Larance B; Bruno R; Mattick R; Hall W; Lintzeris N; Cohen M; Smith K; Degenhardt L, 2015, 'Pharmaceutical Opioid Use and Dependence among People Living with Chronic Pain: Associations Observed within the Pain and Opioids in Treatment (POINT) Cohort', Pain Medicine (United States), 16, pp. 1745 - 1758, http://dx.doi.org/10.1111/pme.12773

Smith K; Mattick RP; Bruno R; Nielsen S; Cohen M; Campbell G; Larance B; Farrell M; Degenhardt L, 2015, 'Factors associated with the development of depression in chronic non-cancer pain patients following the onset of opioid treatment for pain', Journal of Affective Disorders, 184, pp. 72 - 80, http://dx.doi.org/10.1016/j.jad.2015.05.049

Degenhardt L; Bruno R; Ali R; Lintzeris N; Farrell M; Larance B, 2015, 'The introduction of a potentially abuse deterrent oxycodone formulation: Early findings from the Australian National Opioid Medications Abuse Deterrence (NOMAD) study', Drug and Alcohol Dependence, 151, pp. 56 - 67, http://dx.doi.org/10.1016/j.drugalcdep.2015.02.038

Burns L; Gisev N; Larney S; Dobbins T; Gibson A; Kimber J; Larance B; Mattick RP; Butler T; Degenhardt L, 2015, 'A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia', Addiction, 110, pp. 646 - 655, http://dx.doi.org/10.1111/add.12834

Degenhardt L; Bruno R; Lintzeris N; Hall W; Nielsen S; Larance B; Cohen M; Campbell G, 2015, 'Agreement between definitions of pharmaceutical opioid use disorders and dependence in people taking opioids for chronic non-cancer pain (POINT): A cohort study', The Lancet Psychiatry, 2, pp. 314 - 322, http://dx.doi.org/10.1016/S2215-0366(15)00005-X

Nielsen S; Lintzeris N; Bruno R; Campbell G; Larance B; Hall W; Hoban B; Cohen ML; Degenhardt L, 2015, 'Benzodiazepine Use among Chronic Pain Patients Prescribed Opioids: Associations with Pain, Physical and Mental Health, and Health Service Utilization', Pain Medicine (United States), 16, pp. 356 - 366, http://dx.doi.org/10.1111/pme.12594

Degenhardt L; Larance B; Bruno R; Lintzeris N; Ali R; Farrell M, 2015, 'Evaluating the potential impact of a reformulated version of oxycodone upon tampering, non-adherence and diversion of opioids: The National Opioid Medications Abuse Deterrence (NOMAD) study protocol', Addiction, 110, pp. 226 - 237, http://dx.doi.org/10.1111/add.12746

Degenhardt L; Larance B; Peacock A; Farrell M, 2015, 'Reducing extramedical use and harms of pharmaceutical opioids: The potential role of abuse-deterrent formulations', The Lancet Psychiatry, 2, pp. 957 - 959, http://dx.doi.org/10.1016/S2215-0366(15)00331-4

Campbell G; Nielsen S; Bruno R; Lintzeris N; Cohen M; Hall W; Larance B; Mattick RP; Degenhardt L, 2015, 'The Pain and Opioids in Treatment study: Characteristics of a cohort using opioids to manage chronic non-cancer pain', Pain, 156, pp. 231 - 242, http://dx.doi.org/10.1097/01.j.pain.0000460303.63948.8e

Degenhardt L; Blanch B; Gisev N; Larance B; Pearson S, 2015, 'The POPPY Research Programme protocol: Investigating opioid utilisation, costs and patterns of extramedical use in Australia', BMJ Open, 5, pp. e007030, http://dx.doi.org/10.1136/bmjopen-2014-007030

Nielsen S; Bruno R; Campbell G; Cohen M; Farrell M; Hall W; Hoban B; Larance B; Lintzeris N; Mattick R; Degenhardt L, 2015, 'Benzodiazepine use among a sample of chronic pain patients prescribed opioids', Drug and Alcohol Dependence, 146, pp. e52 - e52, http://dx.doi.org/10.1016/j.drugalcdep.2014.09.512

Peacock A; Degenhardt L; Lintzeris N; Larance B; Campbell G; Nielsen S; Cohen M; Bruno R, 2015, 'Opioid therapy for chronic non-cancer pain: Does typology of risk predict aberrant behaviour?', Drug and Alcohol Dependence, 156, pp. e173 - e174, http://dx.doi.org/10.1016/j.drugalcdep.2015.07.471

Campbell G; Nielsen S; Larance B; Bruno R; Mattick R; Hall W; Lintzeris N; Cohen M; Smith K; Degenhardt L, 2015, 'Pharmaceutical opioid use and dependence among people living with chronic pain: Associations observed within the pain and opioids in treatment cohort', Drug and Alcohol Dependence, 156, pp. e35 - e35, http://dx.doi.org/10.1016/j.drugalcdep.2015.07.1013

Larance B; Peacock A; Campbell G; Bruno R; Lintzeris N; Cohen M; Nielsen S; Hall W; Mattick RP; Degenhardt L, 2015, 'Sex differences in alcohol use disorders and risky drinking among chronic non-cancer pain patients receiving opioid therapy', Drug and Alcohol Dependence, 156, pp. e122 - e122, http://dx.doi.org/10.1016/j.drugalcdep.2015.07.336

Degenhardt L; Bruno R; Lintzeris N; Hall W; Nielsen S; Larance B; Cohen M; Campbell G, 2015, 'Xamining DSM and ICD definitions of pharmaceutical opioid dependence in people taking opioids for chronic pain: Findings from the pain and opioids in treatment study', Drug and Alcohol Dependence, 156, pp. e55 - e55, http://dx.doi.org/10.1016/j.drugalcdep.2015.07.1068

Peacock A; Degenhardt L; Hordern A; Larance B; Cama E; White N; Kihas I; Bruno R, 2014, 'Methods and predictors of tampering with a tamper-resistant controlled-release oxycodone formulation', International Journal of Drug Policy, 26, pp. 1265 - 1272, http://dx.doi.org/10.1016/j.drugpo.2015.05.023

Gisev N; Degenhardt L; Larney S; Dobbins T; Larance B; Gibson A; Kimber J; Butler T; Mattick R; Burns L, 2014, 'Treatment Utilisation and Retention with Opioid Substitution Therapy between 2001 and 2010: A Comparison of Buprenorphine and Methadone Users', PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 23, pp. 346 - 347, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000342763600644&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Larance B; Carragher N; Mattick RP; Lintzeris N; Ali R; Degenhardt L, 2014, 'A latent class analysis of self-reported clinical indicators of psychosocial stability and adherence among opioid substitution therapy patients: Do stable patients receive more unsupervised doses?', Drug and Alcohol Dependence, 142, pp. 46 - 55, http://dx.doi.org/10.1016/j.drugalcdep.2014.05.018

Campbell G; Mattick R; Bruno R; Larance B; Nielsen S; Cohen M; Lintzeris N; Shand F; Hall WD; Hoban B; Kehler C; Farrell M; Degenhardt L, 2014, 'Cohort protocol paper: The pain and opioids in treatment (POINT) study', BMC Pharmacology and Toxicology, 15, pp. 17, http://dx.doi.org/10.1186/2050-6511-15-17

Larance B; Lintzeris N; Ali R; Dietze P; Mattick R; Jenkinson R; White N; Degenhardt L, 2014, 'The diversion and injection of a buprenorphine-naloxone soluble film formulation', Drug and Alcohol Dependence, 136, pp. 21 - 27, http://dx.doi.org/10.1016/j.drugalcdep.2013.12.005

Gisev N; Degenhardt L; Larney S; Larance B; Gibson A; Kimber J; Burns L, 2014, 'A comparative study of opioid substitution therapy utilisation among opioid-dependent men and women', Drug and Alcohol Review, 33, pp. 499 - 505, http://dx.doi.org/10.1111/dar.12151

Larance B; Degenhardt L; Mattick R; Ali R; Lintzeris N, 2014, 'Australian post-marketing surveillance studies, 2012', Drug and Alcohol Dependence, 140, pp. e115 - e116, http://dx.doi.org/10.1016/j.drugalcdep.2014.02.331

Nielsen S; Larance B; Lintzeris N; Black E; Bruno R; Murnion B; Dunlop A; Degenhardt L, 2014, 'Is pain associated with illicit opioid use or aberrant opioid-related behaviors in opioid substitution treatment patients', Drug and Alcohol Dependence, 140, pp. e162 - e162, http://dx.doi.org/10.1016/j.drugalcdep.2014.02.456

Nielsen S; Degenhardt L; Larance B; Gowing L; Kehler C; Lintzeris N, 2014, 'Opioid agonist treatment for pharmaceutical opioid dependent people: protocol', Cochrane Database of Systematic Reviews, 5, pp. 1 - 12, http://dx.doi.org/10.1002/14651858.CD011117

Shakeshaft A; Larance B; Degenhardt L; Shand F; Mattick RP; Holiday S; Petrie D; Gorman D, 2013, 'COMMUNITY-LEVEL INTERVENTIONS TO IMPROVE THE TREATMENT OF CHRONIC PAIN AND PRESCRIPTION OF PHARMACEUTICAL OPIOIDS IN GENERAL PRACTICE', DRUG AND ALCOHOL REVIEW, 32, pp. 62 - 62, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000326649400192&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Larance B; Lintzeris N; Ali R; Mattick RP; White N; Jenkinson R; Dietze P; Degenhardt L, 2013, 'THE DIVERSION AND INJECTION OF BUPRENORPHINE-NALOXONE SUBLINGUAL FILM: 2012 FINDINGS FROM THE AUSTRALIAN POST-MARKETING SURVEILLANCE STUDIES', DRUG AND ALCOHOL REVIEW, 32, pp. 46 - 46, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000326649400145&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lintzeris N; Leung S; Dunlop A; Larance BK; White N; Rivas GR; Holland RM; Degenhardt LJ; Muhleisen P; Hurley M; Ali R, 2013, 'A randomised controlled trial of sublingual buprenorphine–naloxone film versus tablets in the management of opioid dependence', Drug and Alcohol Dependence, 131, pp. 119 - 126, http://www.sciencedirect.com/science/article/pii/S0376871612004851#

Nielsen S; Larance BK; Lintzeris N; Black E; Bruno R; Murnion B; Dunlop A; Degenhardt LJ, 2013, 'Correlates of pain in an in-treatment sample of opioid-dependent people', Drug and Alcohol Review, 32, pp. 489 - 494, http://dx.doi.org/10.1111/dar.12041/full

Belcher J; Nielsen S; Campbell G; Bruno R; Hoban B; Larance B; Lintzeris N; Degenhardt L, 2013, 'Diversion of prescribed opioids by people living with chronic pain: Results from an Australian community sample', Drug Alcohol Rev, 33, pp. 27 - 32, http://dx.doi.org/10.1111/dar.12084

Degenhardt LJ; Gilmour S; Shand FL; Bruno R; Campbell G; Mattick RP; Larance BK; Hall W, 2013, 'Estimating the proportion of prescription opioids that is consumed by people who inject drugs in Australia', Drug and Alcohol Review, Advance online publication, pp. 1 - 7, http://dx.doi.org/10.1111/dar.12066/pdf

Larance B; Degenhardt L; O'Brien S; Lintzeris N; Winstock A; Mattick RP; Bell J; Ali R, 2011, 'Prescribers' perceptions of the diversion and injection of medication by opioid substitution treatment patients', Drug and Alcohol Review, 30, pp. 613 - 620, http://dx.doi.org/10.1111/j.1465-3362.2010.00274.x

Larance B; Ambekar A; Azim T; Murthy P; Panda S; Degenhardt L; Mathers B, 2011, 'The availability, diversion and injection of pharmaceutical opioids in South Asia', Drug and Alcohol Review, 30, pp. 246 - 254, http://dx.doi.org/10.1111/j.1465-3362.2011.00304.x

Larance BK; Degenhardt LJ; Lintzeris N; Winstock A; Mattick RP, 2011, 'Definitions related to the use of pharmaceutical opioids: Extramedical use, diversion, non-adherence and aberrant medication-related behaviours', Drug and Alcohol Review, 30, pp. 236 - 245

Larance BK; Degenhardt LJ; Lintzeris N; Bell JR; Winstock A; Dietze P; Mattick RP; Ali RL; Horyniak D, 2011, 'Post-marketing surveillance of buprenorphine-naloxone in Australia: diversion, injection and adherence with supervised administration', Drug and Alcohol Dependence, 118, pp. 265 - 273, http://www.sciencedirect.com/science?_ob=MiamiImageURL&_cid=271276&_user=37161&_pii=S037687161100158X&_check=y&_origin=search&_zone=rslt_list_item&_coverDate=2011-11-01&wchp=dGLzVlt-zSkWA&md5=0d72c20051773c31c9fd0ba175b73028/1-s2.0-S037687161100158X-main.pdf

Larance BK; Degenhardt LJ; O Brien SM; Lintzeris N; Winstock A; Mattick RP; Bell JR; Ali RL, 2011, 'Prescribers' perceptions of the diversion and injection of medication by opiod substitution treatment patients', Drug and Alcohol Review, 30, pp. 613 - 620, http://dx.doi.org/10.1111/j.1465-3362.2010.00274.x/full

Roxburgh AD; Bruno R; Larance BK; Burns L, 2011, 'Prescription of opioid analgesics and related harms in Australia', Medical Journal of Australia, 195, pp. 280 - 284, http://www.mja.com.au/public/issues/195_05_050911/rox11450_fm.html

Larance BK; Ambekar A; Azim T; Murthy P; Panda S; Degenhardt LJ; Mathers BM, 2011, 'The availability, diversion and injection of pharmaceutical opioids in South Asia', Drug and Alcohol Review, 30, pp. 246 - 254, http://dx.doi.org/10.1111/j.1465-3362.2011.00304.x/pdf

Horyniak D; Dietze P; Larance BK; Winstock A; Degenhardt LJ, 2011, 'The prevalence and correlates of buprenorphine inhalation amongst opioid substitution treatment (OST) clients in Australia', International Journal of Drug Policy, 22, pp. 167 - 171, http://dx.doi.org/10.1016/j.drugpo.2010.10.004

Phillips B; Larance B; Burns L, 2010, 'THE PREVALENCE AND CORRELATES OF PAIN AMONG A SAMPLE OF PEOPLE WHO INJECT DRUGS REGULARLY', DRUG AND ALCOHOL REVIEW, 29, pp. 58 - 58, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000284895600154&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Phillips B; Larance B; Burns L, 2009, 'PHARMACEUTICAL OPIOID USE AMONG A GROUP OF PEOPLE WHO INJECT DRUGS IN AUSTRALIA'S LARGEST DRUG MARKET: EXTRA-MEDICAL USE, CHRONIC PAIN AND RISK MANAGEMENT', DRUG AND ALCOHOL REVIEW, 28, pp. A51 - A52, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270916300156&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Degenhardt LJ; Larance BK; Bell JR; Winstock A; Ali RL; Scheuer N; Mattick RP, 2009, 'Injection of medications used in opioid substitution treatment in Australia after the introduction of a mixed partial agonist¿antagonist formulation', Medical Journal of Australia, 191, pp. 161 - 165

Larance B; Degenhardt L; Copeland J; Dillon P, 2008, 'Injecting risk behaviour and related harm among men who use performance- and image-enhancing drugs', Drug and Alcohol Review, 27, pp. 679 - 686, http://dx.doi.org/10.1080/09595230802392568

Roxburgh AD; Degenhardt LJ; Copeland J; Larance BK, 2008, 'Drug dependence and associated risks among female street-based sex workers in the greater Sydney area, Australia', Substance Use and Misuse, 43, pp. 1202 - 1217

Larance BK; Degenhardt LJ; Copeland J; Dillon PG, 2008, 'Injecting risk behaviour and related harm among men who use performance- and image-enhancing drugs', Drug and Alcohol Review, 27, pp. 679 - 686, http://onlinelibrary.wiley.com/doi/10.1080/09595230802392568/abstract

Conference Papers

Larance B; Campbell G; Nielsen S; Bruno R; Lintzeris N; Cohen M; Degenhardt L, 2015, 'HELP-SEEKING FOR OPIOID MEDICATION-RELATED PROBLEMS AMONG A COHORT OF CHRONIC NON-CANCER PAIN PATIENTS PRESCRIBED STRONG OPIOIDS', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL, pp. 39 - 39, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000367694000105&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Holliday S; Dunlop A; Hayes C; Morgan S; Tapley A; Henderson K; Larance B; Shakeshaft A; Magin P, 2015, 'THE EVALUATION OF A BRIEF EDUCATIONAL PAIN MANAGEMENT INTERVENTION AMONGST AUSTRALIAN GENERAL PRACTICE REGISTRARS', in DRUG AND ALCOHOL REVIEW, WILEY-BLACKWELL, pp. 33 - 33, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000367694000091&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Back to profile page